Back to Treatments

Treatment

Nilotinib

1
Conditions
141
Trials
12K
Participants
58%
Average Safety

Condition Evidence

Chronic myeloid leukemia

141 trials · 12K participants

91% effectiveness · 58% safety
Nilotinib | DFDA